Analytical Data
-
Gene name
CHIC2
- Application
-
Alternative Names
BrX-like translocated in leukemia
-
Species
Human
-
Source
E. coli
-
Tag
N- GST
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q9UKJ5
-
Expression Region
1-165aa
-
Molecular Weight
46.3 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
CHIC2, or the "Cysteine-Histidine-Rich Protein 2," is a member of the CHIC family of proteins that has garnered attention due to its potential roles in cellular signaling and development. The protein is characterized by the presence of multiple cysteine and histidine residues, which are crucial for its structural and functional properties. Research into CHIC2 has revealed its involvement in various biological processes, including cell adhesion, migration, and differentiation, making it an important subject of study in both developmental biology and disease research. For instance, aberrant expression of CHIC2 has been linked to several pathologies, including cancer and cardiovascular diseases, prompting investigations into its molecular mechanisms and potential as a therapeutic target. The generation of recombinant CHIC2 protein has facilitated detailed studies of its biochemical properties and interactions, providing insights into its role in health and disease. As a result, understanding the structure-function relationship of CHIC2 through recombinant protein studies holds promise for elucidating its pathways and functions, ultimately paving the way for novel therapeutic strategies aimed at modulating its activity in relevant pathological contexts.
